Dr. Treat
-91%
est. 2Y upside i
“One Medical for pets.”
Rank
#2713
Sector
Pet Health & Wellness
Est. Liquidity
~6Y
Data Quality
Data: LowWhile Dr.
Last updated: February 16, 2026
Dr. Treat successfully scales its tech-enabled membership model, effectively addresses customer service challenges, and expands nationally, leading to a strong Series B or C round with significant valuation growth.
The company achieves moderate growth and expands to a few more locations, but faces ongoing competitive pressures and inconsistent customer experience, resulting in a modest follow-on funding round.
Dr. Treat fails to effectively address negative customer feedback and employee concerns, leading to high churn, inability to secure further funding, and eventual shutdown or distressed asset sale.
Community
Valuation Sentiment
Our model estimates -91% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.